Stock market today: Live updates
Traders work on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., August…
Why Strategy Stock Tumbled on Thursday
Key Points A negative analyst note published before market open on Thursday was the wet blanket that dampened…
Powell to deliver Jackson Hole speech Friday. What Wall Street expects
Federal Reserve Chair Jerome Powell is set to deliver what almost certainly will be his last keynote address…
The S&P 500 heads for a fifth day of declines, but drug stocks are a bright spot
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just…
Sharp market rotation may be winding down — plus, Meta pauses on AI hiring
Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET.…
Under-the-surface market divergence could spell trouble for Wall Street
Breadth isn’t keeping up with the S & P 500 ‘s rally to record levels this summer, according…
Stock market today: Live updates
Stocks making the biggest moves premarket Check out some of the companies making headlines in premarket trading. Walmart…
The Stock Market Has a Serious Problem (Besides President Trump’s Tariffs). History Says This Will Happen Next.
Key Points The U.S. stock market faces two serious problems: tariffs imposed by the Trump administration and a…
Masimo sues U.S Customs over approval of Apple Watch imports
Medical monitoring technology company Masimo sued U.S. Customs and Border Protection on Wednesday over a decision by the…
Trump says U.S. will not approve solar or wind power projects
Wind turbines operate at a wind farm near solar panels near Palm Springs, California, on March 6, 2024.…
Market rotation winners and losers — plus, quantum computing news from one of our industrials
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just…
Rocket Pharma’s shares soar after US FDA lets gene therapy trial resume
Rafael Henrique | SOPA Images | AP The U.S. health regulator has allowed a study of Rocket Pharmaceuticals’…